Pages that link to "Q37996113"
Jump to navigation
Jump to search
The following pages link to Discovery of small molecule cancer drugs: successes, challenges and opportunities (Q37996113):
Displaying 50 items.
- Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment (Q26769963) (← links)
- The Warburg effect and drug resistance (Q26770007) (← links)
- Reassessing the Role of Intra-Arterial Drug Delivery for Glioblastoma Multiforme Treatment (Q26773083) (← links)
- Splicing Regulators and Their Roles in Cancer Biology and Therapy (Q26798158) (← links)
- Exosomic microRNAs in the Tumor Microenvironment (Q26799945) (← links)
- Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance (Q26866517) (← links)
- Clinical Advancements in the Targeted Therapies against Liver Fibrosis. (Q28078684) (← links)
- Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening (Q28080068) (← links)
- An IPTG Inducible Conditional Expression System for Mycobacteria (Q28547068) (← links)
- An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations (Q28552224) (← links)
- Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models (Q28596213) (← links)
- Development of a Whole Organism Platform for Phenotype-Based Analysis of IGF1R-PI3K-Akt-Tor Action. (Q30356087) (← links)
- Microfluidic cell isolation technology for drug testing of single tumor cells and their clusters. (Q30364122) (← links)
- COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo. (Q30367429) (← links)
- Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase (Q30382639) (← links)
- Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development (Q30599549) (← links)
- Molecular tumor board: the University of California-San Diego Moores Cancer Center experience (Q33699863) (← links)
- Unique identifiers for small molecules enable rigorous labeling of their atoms (Q33718167) (← links)
- The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance (Q33836799) (← links)
- The role of GATA2 in lethal prostate cancer aggressiveness (Q33848134) (← links)
- Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets (Q33903831) (← links)
- Combinatorial drug therapy for cancer in the post-genomic era. (Q34287101) (← links)
- Phenotypic screening in cancer drug discovery - past, present and future (Q34429484) (← links)
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. (Q34479551) (← links)
- Transgenic plants as low-cost platform for chemotherapeutic drugs screening (Q35016736) (← links)
- Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays (Q35397776) (← links)
- Medicinal Plants: A Potential Source of Compounds for Targeting Cell Division. (Q35746819) (← links)
- Fibroblast-Derived Extracellular Matrices: An Alternative Cell Culture System That Increases Metastatic Cellular Properties (Q35775737) (← links)
- Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells (Q35835269) (← links)
- Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2. (Q35855216) (← links)
- A High-Throughput Drug Screening Strategy for Detecting Rhodopsin P23H Mutant Rescue and Degradation (Q36009841) (← links)
- Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials. (Q36068377) (← links)
- Target identification for biologically active small molecules using chemical biology approaches (Q36069749) (← links)
- Identification of Novel Human Breast Carcinoma (MDA-MB-231) Cell Growth Modulators from a Carbohydrate-Based Diversity Oriented Synthesis Library. (Q36172912) (← links)
- Biofocussed chemoprospecting: An efficient approach for drug discovery. (Q36264598) (← links)
- Personalized targeted therapy for lung cancer (Q36321826) (← links)
- Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials (Q36534696) (← links)
- Preventive evolutionary medicine of cancers (Q36595780) (← links)
- An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors (Q36779225) (← links)
- Translational research policies: disruptions and continuities in biomedical innovation systems in Austria, Finland and Germany (Q36884593) (← links)
- PRL3-zumab, a first-in-class humanized antibody for cancer therapy. (Q37277211) (← links)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (Q37533025) (← links)
- Peptide-based imaging agents for cancer detection (Q37585965) (← links)
- Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis. (Q37598156) (← links)
- Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer (Q37737611) (← links)
- The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave Roussy (Q38000790) (← links)
- Hypoxia inducible factor pathway inhibitors as anticancer therapeutics. (Q38097867) (← links)
- Expanding the foundation for personalized medicine: implications and challenges for dentistry. (Q38108276) (← links)
- Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test (Q38235827) (← links)
- Cystine-knot peptides: emerging tools for cancer imaging and therapy (Q38243927) (← links)